Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for CGEM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 64.55M
March 31, 2026 61.93M
December 31, 2025 60.24M
September 30, 2025 59.08M
June 30, 2025 59.07M
March 31, 2025 58.70M
December 31, 2024 58.51M
September 30, 2024 58.14M
June 30, 2024 57.87M
March 31, 2024 43.07M
December 31, 2023 42.90M
September 30, 2023 42.76M
June 30, 2023 42.74M
March 31, 2023 39.34M
Date Value
December 31, 2022 45.80M
September 30, 2022 45.74M
June 30, 2022 45.40M
March 31, 2022 44.66M
December 31, 2021 44.29M
September 30, 2021 43.66M
June 30, 2021 43.53M
March 31, 2021 43.52M
December 31, 2020 43.52M
September 30, 2020 43.52M
June 30, 2020 43.52M
March 31, 2020 20.04M
December 31, 2019 43.52M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Rallybio Corp. 5.307M
MapLight Therapeutics, Inc. 45.44M
Arrowhead Pharmaceuticals, Inc. 141.14M
Oncolytics Biotech, Inc. 124.64M
Sangamo Therapeutics, Inc. 414.27M